Press Releases

Stay up to date with press releases covering announcements, company news, product launches, and business updates.

Publish your press release
fallback image
Apr. 30, 2026

VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland

GlobeNewswire, Inc.

fallback image
Apr. 22, 2026

Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration

GlobeNewswire, Inc.

fallback image
May 12, 2026

Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets

GlobeNewswire, Inc.

fallback image
Mar. 30, 2026

Alvotech Files Annual Report with the SEC

GlobeNewswire, Inc.

fallback image
Mar. 18, 2026

Alvotech Q4 2025 and Full Year 2025 Financial Results

GlobeNewswire, Inc.

fallback image
May 29, 2026

Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema

GlobeNewswire, Inc.

fallback image
Jun. 23, 2026

Botanical Lemonade Seltzer Market Forecast Report Featuring Segment Analysis And Strategic Industry Insight

EIN Presswire

fallback image
Mar. 4, 2026

Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire, Inc.

fallback image
Jun. 8, 2026

Green Group World Ocean Day communique

Government of Slovenia

fallback image
Apr. 7, 2026

Oculis to Participate in Upcoming Investor Conferences

GlobeNewswire, Inc.

fallback image
May 22, 2026

European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union

GlobeNewswire, Inc.

fallback image
Jul. 8, 2026

Costco Wholesale Corporation Reports June Sales Results and Announces Quarterly Cash Dividend

GlobeNewswire, Inc.

fallback image
Mar. 18, 2026

VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland

GlobeNewswire, Inc.

fallback image
May 14, 2026

Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights

GlobeNewswire, Inc.

fallback image
May 7, 2026

Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial

GlobeNewswire, Inc.

fallback image
May 7, 2026

Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026

GlobeNewswire, Inc.

fallback image
Jun. 2, 2026

waterproof aprons for kids Market Value Expected To Grow At 8.2% CAGR, Reaching $2.48 Billion By 2030

EIN Presswire

fallback image
Mar. 27, 2026

Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older

GlobeNewswire, Inc.

fallback image
May 14, 2026

Oculis Publishes Results of 2026 Annual General Meeting and Announces Election of Gregory D. Perry to its Board of Directors

GlobeNewswire, Inc.

fallback image
Mar. 18, 2026

VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland

GlobeNewswire, Inc.

Sign up for:

Iceland Health Focus

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by: